Live Longer!
Speaking from Hawaii after attending his first RAADfest (Revolution Against Aging and Death), Mark Hamilton identifies the three obstacles that every anti-aging scientist and biotech CEO faces, and explains why Immortalis is the missing piece that solves all three. Hamilton connects the longevity industry’s practical roadblocks to the deeper philosophical shift from the mortal mentality to the immortal mentality, where value creation, not value production, becomes the foundation for eternal life.
Quick answer
What Are the Three Obstacles to Curing Aging?
After attending RAADfest and listening to leading anti-aging scientists and biotech CEOs, including Dr. Bill Andrews, Liz Parrish, Dr. Greg Fahey, James Stroll, and Bill Faloon, Hamilton identified three obstacles that every one of them faces: (1) overregulation, particularly the FDA’s clinical trial process that takes 10–20 years and costs up to $2 billion; (2) lack of funding, because the regulatory burden makes return on investment too slow for private investors; and (3) lack of public demand for curing aging. Hamilton argues that Immortalis is the missing piece that solves all three: streamlining regulations through a special autonomous zone, making investment viable by dramatically reducing costs and timelines, and generating demand through the Neothink tools that shift people from the mortal mentality into the immortal mentality of value creation.
Frequently asked questions
Related: Starting our own country, The missing key to universal prosperity, Mont Pelerin pivot, A knight in shining armor.
What is RAADfest?
RAADfest stands for Revolution Against Aging and Death. It is a gathering of the world’s most advanced anti-aging scientists and biotech company CEOs, including researchers like Dr. Bill Andrews, Liz Parrish, Dr. Greg Fahey, and Bill Faloon. Hamilton attended his first RAADfest and identified the three universal obstacles these scientists face.
What are the three obstacles to curing aging?
Overregulation (the FDA clinical trial process takes 10–20 years and costs up to $2 billion), lack of funding (investors won’t commit when ROI takes decades), and lack of public demand (most people have not crossed the mental threshold to believe aging can be cured). Hamilton argues Immortalis solves all three.
How does Immortalis solve the regulatory problem?
By streamlining FDA regulations to make clinical trials more efficient without sacrificing safety. Hamilton describes a once-in-a-hundred-year opportunity with the new FDA commissioner willing to work in this direction. The goal: reduce the path to marketplace approval from 10–20 years to 12–18 months.
What is the difference between the mortal and immortal mentality?
The mortal mentality is built on value production, routine work that eventually leads to stagnation and a rut. The immortal mentality is built on value creation, the exhilaration of always moving forward into something new. Hamilton argues that value creation is the essence of human beings and the necessary foundation for eternal life.
What is the division of essence?
Hamilton’s business restructuring concept that replaces the traditional division of labor (where most employees do routine jobs) with a system where every person has their own creative vector of value creation. It is one of the key Neothink tools for shifting from the mortal mentality to the immortal mentality.
Why does Hamilton say Immortalis is different from other special economic zone projects?
Hamilton emphasizes that competitors building special economic zones are doing it for money. Immortalis is doing it for humanitarian purposes, to save lives and cure aging and death. Hamilton calls it our responsibility to prevent human consciousness from perishing.